AZN 65.35 (+1.41%)
US0463531089Drug ManufacturersDrug Manufacturers - General

AstraZeneca (AZN) Stock Highlights

65.35 | +1.41%
2024-12-21 00:04:18
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales.

Statistics

Range Today
63.75 65.46
Volume Today 9.01M
Range 1 Year
60.47 87.68
Volume 1 Year 1.33B
Range 3 Year
52.65 87.68
Volume 3 Year 4.25B
Range 10 Year
25.55 87.68
Volume 10 Year 13.21B

Highlights

Market Capitalization 206.86B (mega)
Floating Shares 1.54B
Current Price 65.35
Price To Earnings 30.88
Price To Revenue 2.47
Price To Book 2.49
Earnings Per Share 2.07
Dividend Yield 2.3%
Dividend Per Share 1.49
Payout Ratio 71.57%

Performance

Latest +1.41%
1 Month +2.29%
3 Months -16.8%
6 Months -16.72%
1 Year -2.01%
3 Years +15.54%
5 Years +29.3%
10 Years +79.73%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.